2.

肝纤维化组与非肝纤维化组的临床资料比较

Comparison of clinical data between the patients with and without hepatic fibrosis

Characteristics	HF group (n=62)	Non-HF group (n=288)	t/Z/χ2	P
HF: Hepatic fibrosis.
Gender [n (%)]			0.761a	0.383
Male	35 (56.45)	145 (50.35)
Female	27 (43.55)	143 (49.65)
Age (year)	31 (27, 36)	29 (23, 36)	1.852	0.064
TG (mmol/L)	1.71 (0.77, 3.27)	0.79 (0.66, 1.02)	5.267	＜0.001
TC (mmol/L)	6.24 (4.66, 6.68)	4.86 (4.15, 5.24)	4.708	＜0.001
LDL-C (mmol/L)	3.68 (2.42, 4.48)	2.83 (2.40, 3.55)	3.926	＜0.001
HDL-C (mmol/L)	1.04 (0.98, 1.23)	1.21 (1.09, 1.32)	4.361	＜0.001
Apo-A1 (g/L)	1.14 (0.76, 1.39)	1.42 (1.14, 1.79)	5.618	＜0.001
Apo-B (g/L)	1.40 (0.95, 2.12)	0.96 (0.72, 1.21)	5.829	＜0.001
Lpa (mg/L)	307.60 (136.98, 432.95)	135.4 (108, 219.5)	5.603	＜0.001
Hcy (μmol/L)	9.70 (6.60, 27.6)	7.35 (5.83, 8.98)	4.003	＜0.001